Monday 17 October 2022

Effects of Banana Starch on Glycemic Response in Obese and Lean Subjects | Chapter 1 | Current Overview on Disease and Health Research Vol. 5

 Former studies have shown the salutary goods of habitual native banana bounce supplementation. In this study, the goods of acute ingestion of native banana bounce on glycemic biographies by means of nonstop glucose monitoring in fat and spare subjects was examined. All actors consumed potables containing either38.3 g of native banana bounce or38.3 g of digestible sludge bounce doubly daily for 4 days. On day 5, a 3- h mess forbearance test was performed to estimate glucose and insulin responses. After 1 week of flop period, treatments were reversed. Native banana bounce supplementation reduced the 48- h glycemia area under the wind in spare, fat, and in the combined group of spare and fat subjects in comparison with digestible sludge bounce. Postprandial glucose and insulin responses at mess forbearance test were reduced after native banana bounce in comparison with digestible sludge bounce in all groups. still, no changes were observed in glycemic variability indicators between groups. In conclusion, acute native banana bounce supplementation bettered postprandial glucose and insulin responses in fat and spare subjects during 48 h of everyday life and at mess forbearance test. farther exploration to interpret the medium behind these changes is needed.


Author(s) Details:

Guadalupe Jiménez-Domínguez,
Endocrinology Department, General Hospital No. 46, Mexican Institute for Social Security, Villahermosa - 86060, Mexico.

Jorge L. Ble-Castillo,
Metabolic Diseases Lab, Research Center, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86150, Mexico.

María A. Aparicio-Trápala,
Academic Division of Agricultural Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86280, Mexico.

Isela E. Juárez-Rojop,
Metabolic Diseases Lab, Research Center, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86150, Mexico.

Carlos A. Tovilla-Zárate,
Multidisciplinary Academic Division of Comalcalco, Comalcalco - 86650, Mexico.

Deysi J. Ble-Castillo,
Scool of Medicine, Montemorelos University, Montemorelos - 67530 Mexico.

Carlos García-Vázquez,
Metabolic Diseases Lab, Research Center, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86150, Mexico.

Viridiana Olvera-Hernández,
Metabolic Diseases Lab, Research Center, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86150, Mexico.

Bedelia Pérez-Pimienta,
Rodolfo Nieto Padrón Children’s Hospital, Secretaria de Salud, Villahermosa - 86150, Mexico.

Juan C. Diaz-Zagoya,
Metabolic Diseases Lab, Research Center, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa - 86150, Mexico.

José D. Méndez,
Medical Research Unit in Metabolic Diseases. Cardiology Hospital. National Medical Center, Mexican Institute of Social Security. México City, México.

Please see the link here: https://stm.bookpi.org/CODHR-V5/article/view/8434

No comments:

Post a Comment